These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28483998)

  • 1. Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
    Ferrari M; Jain IH; Goldberger O; Rezoagli E; Thoonen R; Cheng KH; Sosnovik DE; Scherrer-Crosbie M; Mootha VK; Zapol WM
    Proc Natl Acad Sci U S A; 2017 May; 114(21):E4241-E4250. PubMed ID: 28483998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia ameliorates brain hyperoxia and NAD
    Grange RMH; Sharma R; Shah H; Reinstadler B; Goldberger O; Cooper MK; Nakagawa A; Miyazaki Y; Hindle AG; Batten AJ; Wojtkiewicz GR; Schleifer G; Bagchi A; Marutani E; Malhotra R; Bloch DB; Ichinose F; Mootha VK; Zapol WM
    Mol Genet Metab; 2021 May; 133(1):83-93. PubMed ID: 33752971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired hypoxic pulmonary vasoconstriction in a mouse model of Leigh syndrome.
    Schleifer G; Marutani E; Ferrari M; Sharma R; Skinner O; Goldberger O; Grange RMH; Peneyra K; Malhotra R; Wepler M; Ichinose F; Bloch DB; Mootha VK; Zapol WM
    Am J Physiol Lung Cell Mol Physiol; 2019 Feb; 316(2):L391-L399. PubMed ID: 30520688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leigh Syndrome Mouse Model Can Be Rescued by Interventions that Normalize Brain Hyperoxia, but Not HIF Activation.
    Jain IH; Zazzeron L; Goldberger O; Marutani E; Wojtkiewicz GR; Ast T; Wang H; Schleifer G; Stepanova A; Brepoels K; Schoonjans L; Carmeliet P; Galkin A; Ichinose F; Zapol WM; Mootha VK
    Cell Metab; 2019 Oct; 30(4):824-832.e3. PubMed ID: 31402314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-Specific Defects of Respiratory Capacities in the Ndufs4(KO) Mouse Brain.
    Kayser EB; Sedensky MM; Morgan PG
    PLoS One; 2016; 11(1):e0148219. PubMed ID: 26824698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial response promotes neurodegeneration in the Ndufs4 KO mouse model of Leigh syndrome.
    Aguilar K; Comes G; Canal C; Quintana A; Sanz E; Hidalgo J
    Glia; 2022 Nov; 70(11):2032-2044. PubMed ID: 35770802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome.
    Piroli GG; Manuel AM; Clapper AC; Walla MD; Baatz JE; Palmiter RD; Quintana A; Frizzell N
    Mol Cell Proteomics; 2016 Feb; 15(2):445-61. PubMed ID: 26450614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease.
    Johnson SC; Kayser EB; Bornstein R; Stokes J; Bitto A; Park KY; Pan A; Sun G; Raftery D; Kaeberlein M; Sedensky MM; Morgan PG
    Mol Genet Metab; 2020 Jun; 130(2):118-132. PubMed ID: 32331968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal breathing dysfunction in a mouse model of Leigh syndrome.
    Quintana A; Zanella S; Koch H; Kruse SE; Lee D; Ramirez JM; Palmiter RD
    J Clin Invest; 2012 Jul; 122(7):2359-68. PubMed ID: 22653057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double administration of self-complementary AAV9NDUFS4 prevents Leigh disease in Ndufs4-/- mice.
    Corrà S; Cerutti R; Balmaceda V; Viscomi C; Zeviani M
    Brain; 2022 Oct; 145(10):3405-3414. PubMed ID: 36270002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant BCAA and glutamate metabolism linked to regional neurodegeneration in a mouse model of Leigh syndrome.
    Terburgh K; Coetzer J; Lindeque JZ; van der Westhuizen FH; Louw R
    Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166082. PubMed ID: 33486097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome.
    Quintana A; Kruse SE; Kapur RP; Sanz E; Palmiter RD
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10996-1001. PubMed ID: 20534480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndrome.
    Hanaford AR; Khanna A; James K; Truong V; Liao R; Chen Y; Mulholland M; Kayser EB; Watanabe K; Hsieh ES; Sedensky M; Morgan PG; Kalia V; Sarkar S; Johnson SC
    Neuropathol Appl Neurobiol; 2024 Jun; 50(3):e12977. PubMed ID: 38680020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron status influences mitochondrial disease progression in Complex I-deficient mice.
    Kelly CJ; Couch RK; Ha VT; Bodart CM; Wu J; Huff S; Herrel NT; Kim HD; Zimmermann AO; Shattuck J; Pan YC; Kaeberlein M; Grillo AS
    Elife; 2023 Feb; 12():. PubMed ID: 36799301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gait analysis in a mouse model resembling Leigh disease.
    de Haas R; Russel FG; Smeitink JA
    Behav Brain Res; 2016 Jan; 296():191-198. PubMed ID: 26363424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia as a therapy for mitochondrial disease.
    Jain IH; Zazzeron L; Goli R; Alexa K; Schatzman-Bone S; Dhillon H; Goldberger O; Peng J; Shalem O; Sanjana NE; Zhang F; Goessling W; Zapol WM; Mootha VK
    Science; 2016 Apr; 352(6281):54-61. PubMed ID: 26917594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.
    van de Wal MAE; Adjobo-Hermans MJW; Keijer J; Schirris TJJ; Homberg JR; Wieckowski MR; Grefte S; van Schothorst EM; van Karnebeek C; Quintana A; Koopman WJH
    Brain; 2022 Mar; 145(1):45-63. PubMed ID: 34849584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NAD
    Lee CF; Caudal A; Abell L; Nagana Gowda GA; Tian R
    Sci Rep; 2019 Feb; 9(1):3073. PubMed ID: 30816177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy.
    Bornstein R; James K; Stokes J; Park KY; Kayser EB; Snell J; Bard A; Chen Y; Kalume F; Johnson SC
    Neurobiol Dis; 2022 Feb; 163():105594. PubMed ID: 34933094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of increased intracerebral lactate in a mouse model of Leigh syndrome using proton MR spectroscopy.
    Takahashi Y; Kioka H; Shintani Y; Ohki A; Takashima S; Sakata Y; Higuchi T; Saito S
    Magn Reson Imaging; 2019 May; 58():38-43. PubMed ID: 30668983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.